Triple
T10291822
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | P-glycoprotein |
E241382
|
entity |
| Predicate | affectsPharmacokineticsProcess |
P37860
|
FINISHED |
| Object | drug absorption |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: drug absorption | Statement: [P-glycoprotein, affectsPharmacokineticsProcess, drug absorption]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: affectsPharmacokineticsProcess Context triple: [P-glycoprotein, affectsPharmacokineticsProcess, drug absorption]
-
A.
hasPharmacologicalEffect
Indicates that one entity produces a specific pharmacological effect or action on another entity.
-
B.
isMetabolizedPrimarilyIn
Indicates that the substance undergoes its main metabolic processing within the specified biological system or organ.
-
C.
isMetabolizedBy
Indicates that a substance is biochemically broken down or transformed through metabolic processes carried out by a specified organism, cell type, or enzyme system.
-
D.
hasBioavailability
Indicates that a substance has a specified degree or measure of bioavailability, i.e., the proportion that enters circulation and can have an active effect.
-
E.
affectsBiologicalProcess
chosen
Indicates a relationship where one entity produces a change or influence on a biological process of another entity or system.
- F. None of above.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d381aaafc08190af475ef58dc16aba |
completed | April 6, 2026, 9:49 a.m. |
| NER | Named-entity recognition | batch_69d4d7ccb7ec8190a538cf279e48116e |
completed | April 7, 2026, 10:09 a.m. |
| PD | Predicate disambiguation | batch_69d4d1f117708190928f92ae2611d724 |
completed | April 7, 2026, 9:44 a.m. |
Created at: April 6, 2026, 11:42 a.m.